As concerns SERPINE1 and PLAU, their involvement in modulating breast cancer cell motility and invasiveness is well established15, therefore we decided to test the effects on cell motility of the other two (LGMN and NRP2). The gene discussed is NRP2; the disease is breast carcinoma.